Recent Questions and Answers about Etoposide
What are different types of drugs that are used for leukemia?
View Community-reported Etoposide side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Etoposide Side Effect
Have You dealt with a Etoposide side effect? Share your experience
Etoposide Side Effects summary
Total Etoposide reports: 224.Etoposide FDA safety alerts: No.
Reported deaths: 113 Reported hospitalizations: 101.
Take Etoposide Side Effects Survey, Discuss Etoposide with others
Etoposide Side Effects: asthenia, dehydration, febrile neutropenia, leukopenia, pneumonia, neutropenic sepsis, renal failure acute, renal failure, thrombocytopenia, pyrexia, dyspnoea,
Etoposide Usage.
If you have questions about Etoposide, you can ask a Health Expert or Ask Patient Community about Etoposide.
Etoposide Side Effects reported to FDA
< Previous Showing 121-160 of 224 Next >
Etoposide Side Effects Report #5396874-0Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on July 25, 2007. Male patient, 32 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, multi-organ failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with LOMUSTINE. Patient died.
Etoposide Side Effects Report #5398979-7
ETOPOSIDE problem was reported by a Physician from BELGIUM on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis. ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5401740-8
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on July 27, 2007. Female patient, child 2 years of age, was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5402051-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Male patient, 20 years of age, was diagnosed with brain neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma. ETOPOSIDE dosage: 75 MG/M2/DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died.

Etoposide Side Effects Report #5379691-7
Consumer or non-health professional from JAPAN reported ETOPOSIDE problem on June 29, 2007. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, duodenal ulcer haemorrhage, infection, pleural effusion. ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient died.
Etoposide Side Effects Report #5379824-2
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 03, 2007. Male patient, child 5 years of age, weighting 33.07 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: oxygen saturation decreased, pyrexia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, MESNA, SEPTRIN, VINCRISTINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5381456-7
Consumer or non-health professional from NETHERLANDS reported ETOPOSIDE problem on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Etoposide Side Effects Report #5385467-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, renal failure acute, sepsis, supraventricular tachycardia. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/14/2007.
Etoposide Side Effects Report #5385990-5
Physician from GERMANY reported ETOPOSIDE problem on June 26, 2007. Male patient, 19 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chills, circulatory collapse, headache, hypersensitivity, nausea, septic shock, vomiting. ETOPOSIDE dosage: 100 MG/M2 INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5388593-1
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, hypoxia, lung consolidation, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5391223-6
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 06, 2007. Male patient, 65 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral infarction. ETOPOSIDE dosage: 570MG/IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5392130-5
ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 18, 2007. Male patient, weighting 39.68 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cystitis haemorrhagic, enteritis, graft complication, immunosuppression, multi-organ failure, neutrophil count decreased, platelet count decreased, pneumonia adenoviral. ETOPOSIDE dosage: 140MG. During the same period patient was treated with CISPLATIN, FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, MESNA. Patient died on 06/25/2007.
Etoposide Side Effects Report #5395327-3
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on July 23, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5396874-0
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 25, 2007. Male patient, 32 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, multi-organ failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with LOMUSTINE. Patient died.

Etoposide Side Effects Report #5398979-7
Physician from BELGIUM reported ETOPOSIDE problem on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis. ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5401740-8
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 27, 2007. Female patient, child 2 years of age, was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5402051-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 17, 2007. Male patient, 20 years of age, was diagnosed with brain neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma. ETOPOSIDE dosage: 75 MG/M2/DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5757208-2
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on June 02, 2008. Male patient, 75 years of age, weighting 183.0 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration, dizziness, muscular weakness, nausea, renal failure acute, vomiting. ETOPOSIDE dosage: INITIALLY STARTED ON 29APR08-STOPPED:100MG, EVERY DAY ON DAYS 1-3+ 8-10 OF 28-DAY CYCLE. During the same period patient was treated with TIPIFARNIB. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5760253-4
Health Professional from UNITED STATES reported ETOPOSIDE problem on May 20, 2008. Male patient, 67 years of age, weighting 103.6 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis. ETOPOSIDE dosage: 144MG. Patient died on 11/06/2007.

Etoposide Side Effects Report #5760255-8
ETOPOSIDE problem was reported by a Consumer or non-health professional from INDIA on May 14, 2008. Male patient, 67 years of age, weighting 103.6 lb, was diagnosed with small cell lung cancer extensive stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis. ETOPOSIDE dosage: 144 MG, DAY 1,2 AND 3 OF 21 DAY CYCLE INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, LORAZEPAM, RABEPRAZOLE, DOMPERIDONE, TAMSULOSIN. Patient died.
Etoposide Side Effects Report #5765913-7
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Mar 12, 2008. Male patient, child 2 years of age, weighting 30.86 lb, was diagnosed with bone marrow conditioning regimen, pyrexia, pulmonary embolism and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchospasm. ETOPOSIDE dosage: unknown. During the same period patient was treated with MELPHALAN, CARBOPLATIN, CEFEPIME, SEPTRA, HEPARIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5766921-2
ETOPOSIDE problem was reported by a Physician from ISRAEL on Nov 09, 2007. Female patient was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE, CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5777079-8
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on June 17, 2008. Male patient, weighting 110.9 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: heart rate decreased. ETOPOSIDE dosage: 100MG DAILY ONCE IV. During the same period patient was treated with ALLOPURINOL, ATORVASTATIN, CEFEPIME, DIGOXIN, DIPHENHYDRAMINE, HYDRALAZINE, HYDROXYZINE. Patient recovered.
Etoposide Side Effects Report #5777931-3
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2008. Female patient, weighting 93.26 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bradycardia, candidiasis, culture throat positive, hypotension, hypoxia, liver function test abnormal, mucosal inflammation, neutropenia. ETOPOSIDE dosage: 650 MG. During the same period patient was treated with IFOSFAMIDE, MESNA. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5780014-X
Health Professional from CZECH REPUBLIC reported ETOPOSIDE problem on June 17, 2008. Male patient, 16 years of age, was diagnosed with glioblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: facial palsy, glioblastoma multiforme. ETOPOSIDE dosage: DOSE- 50 MG/M2 1-21 DAY. During the same period patient was treated with TEMOZOLOMIDE. Patient died on 07/12/2007.
Etoposide Side Effects Report #5781343-6
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, BUSULFAN, NEUPOGEN, DAUNORUBICIN, FLUDARABINE, MELPHALAN. Patient recovered.
Etoposide Side Effects Report #5781346-1
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 16, 2008. Male patient, 42 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, IDARUBICIN, MELPHALAN, MITOXANTRONE. Patient recovered.
Etoposide Side Effects Report #5781347-3
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 16, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, DAUNORUBICIN, MELPHALAN, MITOXANTRONE. Patient died.
Etoposide Side Effects Report #5781348-5
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 16, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, LEUKINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.
Etoposide Side Effects Report #5797752-5
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, complications of transplant surgery, myelodysplastic syndrome, stem cell transplant. ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, BUSULFAN. Patient died.
Etoposide Side Effects Report #5797753-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 19, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemia recurrent, myelodysplastic syndrome. ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with MITOXANTRONE, CYTARABINE, DAUNORUBICIN, MELPHALAN. Patient died.
Etoposide Side Effects Report #5797754-9
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: 100 MG/M**2; DAILY. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.
Etoposide Side Effects Report #5734308-4
Health Professional from TURKEY reported ETOPOSIDE problem on May 08, 2008. Female patient, 29 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, panniculitis, vomiting. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, ASPARAGINASE, CYTARABINE, IDARUBICIN, METHOTREXATE, PREDNISOLONE. Patient recovered.
Etoposide Side Effects Report #5737332-0
ETOPOSIDE problem was reported by a Health Professional from TURKEY on May 12, 2008. Female patient, 29 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, panniculitis, vomiting. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, ASPARAGINASE, CYTARABINE, IDARUBICIN, METHOTREXATE, PREDNISOLONE. Patient recovered.
Etoposide Side Effects Report #5738429-1
Physician from UNITED STATES reported ETOPOSIDE problem on May 02, 2008. Female patient, child 3 years of age, was diagnosed with malignant histiocytosis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease complication, epstein-barr virus infection, fungal infection, lymphoproliferative disorder. ETOPOSIDE dosage: unknown. During the same period patient was treated with PREDNISONE, VINBLASTINE SULPHATE, MERCAPTOPURINE, METHOTREXATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5741353-1
ETOPOSIDE problem was reported by a Physician from JAPAN on May 06, 2008. Male patient, child 4 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, oesophageal varices haemorrhage, venoocclusive liver disease. ETOPOSIDE dosage: 60 MG/KG. During the same period patient was treated with BUSULPHAN, MELPHALAN, CYCLOPHOSPHAMIDE, TETRAHYDROPYRANYL, VINCRISTINE, CISPLATIN. Patient recovered.
Etoposide Side Effects Report #5742171-0
Health Professional from CZECH REPUBLIC reported ETOPOSIDE problem on May 14, 2008. Male patient, child 2 years of age, was diagnosed with juvenile chronic myelomonocytic leukaemia, neurofibromatosis, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, hepatosplenomegaly, liver disorder, mucosal haemorrhage, multi-organ failure, pancytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOSPORINE. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5745790-0
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 06, 2008. Male patient, 73 years of age, weighting 123.5 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cold sweat, visceral oedema. ETOPOSIDE dosage: 171 MG. Patient was hospitalized. Patient died on 10/19/2006.
Etoposide Side Effects Report #5747157-8
Health Professional from UNITED STATES reported ETOPOSIDE problem on May 06, 2008. Male patient, 73 years of age, weighting 123.5 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cold sweat, visceral oedema. ETOPOSIDE dosage: 171 MG. Patient was hospitalized. Patient died on 10/19/2006.
Etoposide Side Effects Report #5747732-0
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 180.8 lb, was diagnosed with small cell lung cancer extensive stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: candidiasis, dysphagia, mucosal inflammation, neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, ALBUTEROL, ATROVENT, TOPROL, POTASSIUM CHLORIDE, TUSSIONEX. Patient was hospitalized. Patient recovered.
< Previous Showing 121-160 of 224 Next >
Etoposide Side Effects


